CBIH — Cannabis Bioscience International Holdings Share Price
Last trade - 00:00- $8.31m
- $17.45m
- $83.46m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.16 | ||
| Price to Tang. Book | 0.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.2 | ||
| EV to EBITDA | 1.47 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.65% | ||
| Return on Equity | 10.89% | ||
| Operating Margin | 21.56% | ||
Financial Summary
| Year End 31st May | Unit | 2007 | 2008 | 2009 | 2010 | 2011 | 2012E | 2013E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 39.3 | 66.78 | 74 | 83.46 | n/a | n/a | 441.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +84.89 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cannabis Bioscience International Holdings, Inc. provides educational and other services to the cannabis industry. The Company provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The Company’s segments include Pharmacology University Business and Alpha Research Business. Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. These trials have included drugs relating to diseases in the areas of asthma, allergies, renal disorders, neurology disorders, cardiac and vascular disorders and others.
Directors
- Last Annual
- May 31st, 2011
- Last Interim
- February 29th, 2012
- Incorporated
- February 28th, 2003
- Public Since
- September 25th, 2009
- No. of Shareholders
- 296
- No. of Employees
- 389
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 10,381,749,347
- Address
- 6201 BONHOMME ROAD, SUITE 466S, HOUSTON, 77036
- Web
- https://www.cbih.net/
- Phone
- +1 2147330868
- Auditors
- Child , Van Wagoner & Bradshaw , PLLC
Upcoming Events for CBIH
Similar to CBIH
Acorda Therapeutics
Pink Sheets on Nasdaq
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
FAQ
As of Today at 19:48 UTC, shares in Cannabis Bioscience International Holdings are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Cannabis Bioscience International Holdings last closed at $0.00 and the price had moved by +120% over the past 365 days. In terms of relative price strength the Cannabis Bioscience International Holdings share price has outperformed the S&P500 Index by +84.64% over the past year.
There is no consensus recommendation for this security.
Cannabis Bioscience International Holdings does not currently pay a dividend.
Cannabis Bioscience International Holdings does not currently pay a dividend.
Cannabis Bioscience International Holdings does not currently pay a dividend.
To buy shares in Cannabis Bioscience International Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Cannabis Bioscience International Holdings had a market capitalisation of $11.42m.
Here are the trading details for Cannabis Bioscience International Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CBIH
Based on an overall assessment of its quality, value and momentum Cannabis Bioscience International Holdings is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cannabis Bioscience International Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -0.39%.
As of the last closing price of $0.00, shares in Cannabis Bioscience International Holdings were trading +57.41% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cannabis Bioscience International Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cannabis Bioscience International Holdings' management team is headed by:
- David Cutler - CEO